Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Blood|June 4, 2017
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMMLAkihide Yoshimi, Maria E Balasis, Alexis Vedder, et al.Cancer Cell|August 15, 2018
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene MutationsStanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, et al.Blood|June 13, 2015
Recurrent CDKN1B (p27) mutations in hairy cell leukemiaSascha Dietrich, Jennifer Hüllein, Stanley Chun-Wei Lee, et al.Cancer Discovery|July 10, 2019
Altered Nuclear Export Signal Recognition as a Driver of OncogenesisJustin Taylor, Maria Sendino, Alexander N Gorelick, et al.Nature|September 15, 2015
BET inhibitor resistance emerges from leukaemia stem cellsChun Yew Fong, Omer Gilan, Enid Y N Lam, et al.The Journal of Clinical Investigation|December 20, 2019
Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemiaSzymon Klossowski, Hongzhi Miao, Katarzyna Kempinska, et al.Nature|October 4, 2019
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesisAkihide Yoshimi, Kuan-Ting Lin, Daniel H Wiseman, et al.Nature Medicine|February 20, 2018
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancersMichael Seiler, Akihide Yoshimi, Rachel Darman, et al.Cancer Cell|August 14, 2019
Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine MethylationJia Yi Fong, Luca Pignata, Pierre-Alexis Goy, et al.Cancer Discovery|November 15, 2015
Diverse and Targetable Kinase Alterations Drive Histiocytic NeoplasmsEli L Diamond, Benjamin H Durham, Julien Haroche, et al.Pageof 5